Canadian innovator’s device creates new gold standard for measuring patients’ snoring and sleep apnea at home
OTTAWA, September 16, 2015 – BRAEBON Snoring & Sleep Apnea will debut its upgraded MediByte® home snoring and sleep apnea recorder at MEDICA 2015, the world’s largest annual medical trade fair November 16 -19 in Dusseldorf, Germany. Validated in peer-reviewed scientific journals, the MediByte system allows clinicians to easily, reliably and accurately measure, as never before, the stages of sleep and breathing during sleep – all in the comfort of patients’ homes.
Braebon’s MediByte system is the world’s smallest sleep apnea recorder capable of measuring electrophysiological stages of sleep. It combines pulse oximetry, position measurement, airflow measurement, ventilatory effort and electrophysiology – all measures traditionally found only in hospital sleep laboratories – into a powerful yet easy-to-use miniature recorder which is conveniently used in the comfort of the home. The recorder picks up highly accurate data about the patients’ sleep, which may then be uploaded to the Braebon cloud portal. This allows medical and dental specialists to conveniently yet securely assess how sleep apnea patients are doing and adjust their treatment accordingly.
“MediByte is truly a gold standard for how medical devices can be powerful yet comfortable for patients to wear and easy to use at home,” says Dr. Richard Bonato, Braebon’s CEO and co-founder. “MediByte’s measurement capabilities alone make it demonstrably superior to other product designs. They are a result of Braebon’s decades-long experience in medical device design and so we are particularly proud to be announcing such an innovative product at Medica 2015 to the world.
“Last year, our debut at Medica 2014 was a very successful. We were able to meet with numerous prospective new customers, strengthen business relationships with existing international distributors, and follow up with key international suppliers in a very efficient and expedient fashion. This international presence allows us to combine numerous marketing objectives, such as new product introduction, training, interviewing critical suppliers, etc., with one business trip.”
Dr. Bonato predicts that MediByte’s ability to inexpensively and reliably measure snoring and sleep apnea, both at pre-treatment baseline and post-treatment follow-up, will make it a must-have for doctors, dentists, and other healthcare providers alike: “We believe such accurate diagnosis and treatment monitoring will boost overall growth in respiratory medicine and in the burgeoning dental-sleep medicine market.”
Dr. Bonato credits MediByte’s innovative nature to the company’s unique “Test Treat Trac” development approach, which engages clinicians across multiple disciplines to collaborate and find better, more reliable tools to treat the sleep apnea patient.
“Sleep apnea is a growing worldwide epidemic and Braebon is well positioned with our home sleep apnea testing equipment to both diagnose and manage sleep apnea treatment outcomes – without requiring the patient having to go to a sleep clinic and undergo an expensive and inconvenient sleep laboratory procedure,” says Dr. Bonato. “Now patients have a choice of where they can undergo testing procedures.”
Donald Bradley, Braebon’s CTO and co-founder: “Our challenge was to develop a miniaturized, user-friendly yet sophisticated measurement technology using the same technology found in leading hospital facilities. We had to rethink the use-case scenarios and create a novel and powerful solution. The level of product sophistication connected with our cloud portal is beyond anything we’ve done before. I’m very proud of what our team has accomplished.”
BRAEBON has distributors on six continents and is actively seeking new innovative distribution channel partners in the European Union and other countries. In North America, BRAEBON is working with numerous leading medical facilities and dental laboratories, and is actively seeking distributors for all products in other parts of the world.
About BRAEBON Medical Corporation
BRAEBON is a privately held Canadian corporation and has been in business since 1998 developing and manufacturing medical devices for snoring and sleep apnea in their ISO 13485 manufacturing facility. BRAEBON’s products are sold worldwide for use in the Sleep Medicine and Dental Sleep Medicine fields. BRAEBON is a world leader in portable home sleep apnea testing devices with its MediByte® and MediByte Jr.® recorders as well as its line of sleep sensors and accessories. The Founders of BRAEBON were the original designers of a leading sleep laboratory recording technology which became dominant during the transition from paper to digital recording 20 years ago.
To find out more about MediByte, DentiTrac, and Breabon’s other sleep products and services, please visit us during MEDICA at the Ontario/Canada Pavilion, Hall 16, Booth G42.
In the meantime, we invite you to watch this informative video – www.youtube.com/watch?v=i-vmutcqyv4 – about Braebon’s BridgeBuilder Cloud Portal.
For additional information, contact Richard Bonato, CEO, by telephone at +01.613.831.6690 x202, via email at firstname.lastname@example.org or visit www.braebon.com for more on BRAEBON Medical Corporation.